Comparing physical health in children with esophageal atresia and healthy peers
Official title: Comparison of Symptoms, Pulmonary Function, Muscle Strength, Exercise Capacity, and Frailty Level in Individuals With Esophageal Atresia and Healthy Individuals
Run by Hacettepe University · NCT06975982 · Data updated 2026-11-12
This study looks at how the physical health of children with esophageal atresia compares to that of healthy kids to see how the condition affects things like strength, exercise, and overall well-being.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 6 Years to 18 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara, Ankara) |
| Status | Recruiting |
| Started | October 24, 2024 |
| Main results expected | October 24, 2027 |
| Study ends | October 24, 2027 |
| Registry record updated | May 29, 2025 |
| Trial ID | NCT06975982 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 6-18 with a diagnosis of esophageal atresia who can cooperate with the assessments.
✕Probably not a fit
Patients with orthopedic, neurological, or cardiovascular issues that may affect assessments, or those with recent respiratory infections, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate and compare various physical characteristics, including pulmonary function, muscle strength, exercise capacity, and quality of life, between children diagnosed with esophageal atresia and their healthy peers. By assessing factors such as body composition, peak cough flow, and fatigue levels, the study seeks to understand the impact of esophageal atresia on overall physical health and well-being. Participants will include children aged 6-18 from both groups, with specific inclusion and exclusion criteria to ensure accurate results.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the physical challenges faced by children with esophageal atresia, leading to improved management and support strategies.
How similar studies have gone: While there may be studies on related conditions, this specific comparison of esophageal atresia with healthy peers is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Esophageal atresia group Inclusion Criteria: * Children with esophageal atresia who are willing to participate in the study * Being between the ages of 6-18, * Being able to cooperate with the assessments Exclusion Criteria: * Being unable to cooperate with the assessments, * Having an orthopedic, neurological or cardiovascular problem that may affect the assessments, * Having a lung infection or upper respiratory tract infection in the last four weeks, * Being an active smoker, * Not being willing to participate in the study, Control group Inclusion Criteria: * Being between the ages of 6-18, * Being willing to cooperate with the tests to be performed, * Being willing to participate in the study. Exclusion Criteria: * Having a musculoskeletal problem that may affect exercise performance, * Having any known chronic disease, * Having a lung infection or upper respiratory tract infection in the last four weeks, * Being an active smoker, * Not willing to participate in the study.
Where it's running
-
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Ankara, Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Meltem Yildiz-Kayaoglu, MD — Hacettepe University
- Study coordinator: Aslihan Cakmak-Onal, PhD, PT
- Email: aslihancakmak90@gmail.com
- Phone: +90 312 305 15 76
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prevention with PMBL for recurrent RTIs in kids
This study tests whether PMBL sublingual tablets can help prevent recurrent respiratory tract infections in children aged 3–12 compared to a placebo.
-
Bifidobacterium XLTG11 to support growth, immune health, and reduce allergies in infants at higher allergy risk
This trial tests whether daily Bifidobacterium animalis subsp. lactis XLTG11 for 180 days can reduce allergic, respiratory, and gastrointestinal symptoms and change gut microbiome and immune markers in infants under 3 with higher allergy risk.
-
Outdoor science education to improve learning and well-being in primary school children
This project will test whether giving 5th and 6th grade students outdoor science lessons instead of indoor lessons helps their learning, connection to nature, eco-anxiety, and stress.
-
Balloon inflation time for esophageal narrowing after atresia repair
This trial will try different balloon inflation times during endoscopic dilation to see which works best for children with narrowing after esophageal atresia repair.
-
Functional training versus dynamic play to improve motor skills, fitness, and balance in 7–10-year-old children
This trial will test whether functional training or dynamic play better improves gross motor skills, physical fitness, and balance in healthy children aged 7–10.
-
Translation of a mobility assessment tool for healthy children into Urdu
This study is trying to translate a mobility assessment tool into Urdu to see if it can accurately measure how well healthy children aged 5-12 can move.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.